NCT07705204

Brief Summary

The goal of this observational study is to learn about the incidence and characteristics of adverse events (AEs) among hospitalized patients in China and to compare 4 commonly used methods for detecting these events. The main questions it aims to answer are: How common are AEs among hospitalized patients, and what are their characteristics (types, severity, and preventability) in China? How do 4 commonly used methods, including the Harvard Medical Practice Study (HMPS), Global Trigger Tool (GTT), Patient Safety Indicators (PSIs), and incident reporting systems (IRSs), compare in detecting AEs? Researchers review randomly selected medical records from 5 hospitals in China to identify AEs, assess their type, severity, and preventability, and evaluate the performance of the 4 detection methods.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,807

participants targeted

Target at P75+ for all trials

Timeline
2mo left

Started Aug 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Aug 2025Oct 2026

Study Start

First participant enrolled

August 28, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 11, 2026

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 6, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 15, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Expected
Last Updated

July 15, 2026

Status Verified

July 1, 2026

Enrollment Period

7 months

First QC Date

July 6, 2026

Last Update Submit

July 10, 2026

Conditions

Keywords

Adverse event (AE)Harvard Medical Practice Study (HMPS)Global Trigger Tool (GTT)Patient Safety Indicator (PSI)Incident Reporting System (IRS)Patient Safety

Outcome Measures

Primary Outcomes (1)

  • Adverse event incidence

    The proportion of admissions with at least one adverse event.

    During the index admission, including review of relevant prior hospitalization records and all available records through 30 days after discharge.

Secondary Outcomes (7)

  • Types of adverse event

    During the index admission, including review of relevant prior hospitalization records and all available records through 30 days after discharge

  • Preventability of adverse event

    During the index admission, including review of relevant prior hospitalization records and all available records through 30 days after discharge

  • Severity of adverse events

    During the index admission, including review of relevant prior hospitalization records and all available records through 30 days after discharge

  • Sensitivity of adverse event detection methods

    After completion of AE screening, adjudication, and re-review of randomly sampled screen-negative admissions

  • Specificity of adverse event detection methods

    After completion of AE screening, adjudication, and re-review of randomly sampled screen-negative admissions

  • +2 more secondary outcomes

Interventions

This is a retrospective cross-sectional study based on medical record review. The study assesses AE incidence and characteristics and compares AE detection methods, with no intervention administered to participants.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population consisted of inpatient admissions to 5 participating public general hospitals in Beijing, China, during 2024. Eligible admissions were identified according to predefined inclusion and exclusion criteria. Stratified random sampling was used, with sample sizes allocated in proportion to hospital admission volumes. Within each site, eligible admissions were randomly selected with equal selection probabilities. The final study sample included 2,843 admissions.

You may qualify if:

  • age ≥18 years and a length of stay of at least 24 hours

You may not qualify if:

  • Patients admitted primarily for psychiatric disorders, palliative care, or rehabilitation were excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College

Beijing, Beijing Municipality, 100730, China

Location

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 6, 2026

First Posted

July 15, 2026

Study Start

August 28, 2025

Primary Completion

March 11, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

July 15, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations